Adamas Signs $100 Million Royalty-Backed Note Agreement with HealthCare Royalty Partners
11 mai 2017 09h11 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that it has entered into a $100 million royalty-backed note agreement with HealthCare...